Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2022 | May 09, 2022 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Mar. 31, 2022 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 001-41017 | |
Entity Registrant Name | Mercato Partners Acquisition Corporation | |
Entity Central Index Key | 0001853436 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 86-2230021 | |
Entity Address, Address Line One | 2750 E. Cottonwood Parkway Suite #500 | |
Entity Address, City or Town | Cottonwood Heights | |
Entity Address, State or Province | UT | |
Entity Address, Postal Zip Code | 84121 | |
City Area Code | 801 | |
Local Phone Number | 220-0055 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | true | |
Common Class A [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A Common Stock, par value $0.0001 per share | |
Trading Symbol | MPRA | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 23,000,000 | |
Common Class B [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 5,750,000 | |
Capital Units [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A Common Stock and one-half of one Warrant | |
Trading Symbol | MPRAU | |
Security Exchange Name | NASDAQ | |
Warrant [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Warrants, each whole Warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share | |
Trading Symbol | MPRAW | |
Security Exchange Name | NASDAQ |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash | $ 249,854 | $ 387,206 |
Prepaid expenses - current | 454,838 | 478,734 |
Total current assets | 704,692 | 865,940 |
Prepaid expenses - long-term | 0 | 42,295 |
Investments held in Trust Account | 233,471,280 | 233,450,000 |
Total Assets | 234,175,972 | 234,358,235 |
Current liabilities: | ||
Accounts payable | 149,901 | 86,149 |
Accrued expenses | 126,813 | 133,172 |
Franchise tax payable | 85,789 | 37,022 |
Total current liabilities | 362,503 | 256,343 |
Derivative liabilities | 6,896,000 | 12,930,000 |
Deferred underwriting commissions | 8,050,000 | 8,050,000 |
Total Liabilities | 15,308,503 | 21,236,343 |
Commitments and Contingencies | ||
Class A common stock subject to possible redemption; 23,000,000 shares at redemption value of $10.15 per share as of March 31, 2022 and December 31, 2021 | 233,450,000 | 233,450,000 |
Stockholders' Deficit: | ||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 | 0 |
Additional paid-in capital | 0 | 0 |
Accumulated deficit | (14,583,106) | (20,328,683) |
Total stockholders' deficit | (14,582,531) | (20,328,108) |
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders' Deficit | 234,175,972 | 234,358,235 |
Class A Common Stock [Member] | ||
Stockholders' Deficit: | ||
Common stock value | 0 | 0 |
Class B Common Stock [Member] | ||
Stockholders' Deficit: | ||
Common stock value | $ 575 | $ 575 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2022 | Dec. 31, 2021 |
Temporary equity, Redemption price per share | $ 10.15 | |
Preferred stock, Par or stated value per share | $ 0.0001 | $ 0.0001 |
Preferred stock, Shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, Shares issued | 0 | 0 |
Preferred stock, Shares outstanding | 0 | 0 |
Class A Common Stock [Member] | ||
Temporary equity, Shares outstanding | 23,000,000 | 23,000,000 |
Temporary equity, Redemption price per share | $ 10.15 | $ 10.15 |
Common stock, Par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock, Shares authorized | 100,000,000 | 100,000,000 |
Common stock, Shares issued | 0 | 0 |
Common stock, Shares outstanding | 0 | 0 |
Class B Common Stock [Member] | ||
Common stock, Par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock, Shares authorized | 10,000,000 | 10,000,000 |
Common stock, Shares issued | 5,750,000 | 5,750,000 |
Common stock, Shares outstanding | 5,750,000 | 5,750,000 |
Unaudited Condensed Statements
Unaudited Condensed Statements Of Operations - USD ($) | 1 Months Ended | 3 Months Ended |
Mar. 31, 2021 | Mar. 31, 2022 | |
General and administrative expenses | $ 4,496 | $ 260,936 |
Franchise tax expenses | 618 | 48,767 |
Loss from operations | (5,114) | (309,703) |
Other income: | ||
Change in fair value of derivative liabilities | 0 | 6,034,000 |
Income from investments held in Trust Account | 0 | 21,280 |
Net income (loss) | (5,114) | 5,745,577 |
Class A Common Stock [Member] | ||
Other income: | ||
Net income (loss) | $ 0 | $ 4,596,462 |
Weighted average shares outstanding, basic and diluted | 0 | 23,000,000 |
Basic and diluted net loss per share | $ 0 | $ 0.20 |
Class B Common Stock [Member] | ||
Other income: | ||
Net income (loss) | $ (5,114) | $ 1,149,115 |
Weighted average shares outstanding, basic and diluted | 3,684,211 | 5,750,000 |
Basic and diluted net loss per share | $ 0 | $ 0.20 |
Unaudited Condensed Statement_2
Unaudited Condensed Statements of Changes in Stockholders' Equity (Deficit) - USD ($) | Total | Additional Paid-In Capital [Member] | Accumulated Deficit [Member] | Class A Common Stock [Member] | Class A Common Stock [Member]Common Stock [Member] | Class B Common Stock [Member] | Class B Common Stock [Member]Common Stock [Member] |
Beginning balance, Shares at Feb. 21, 2021 | 0 | 0 | |||||
Beginning balance at Feb. 21, 2021 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||
Net income (loss) | (5,114) | (5,114) | $ 0 | $ (5,114) | |||
Issuance of Class B common stock to Sponsor, Shares | 5,750,000 | ||||||
Issuance of Class B common stock to Sponsor | 25,000 | 24,425 | $ 575 | ||||
Ending balance, Shares at Mar. 31, 2021 | 0 | 5,750,000 | |||||
Ending balance at Mar. 31, 2021 | 19,886 | 24,425 | (5,114) | $ 0 | $ 575 | ||
Beginning balance, Shares at Dec. 31, 2021 | 0 | 5,750,000 | |||||
Beginning balance at Dec. 31, 2021 | (20,328,108) | 0 | (20,328,683) | $ 0 | $ 575 | ||
Net income (loss) | 5,745,577 | 5,745,577 | $ 4,596,462 | $ 1,149,115 | |||
Ending balance, Shares at Mar. 31, 2022 | 0 | 5,750,000 | |||||
Ending balance at Mar. 31, 2022 | $ (14,582,531) | $ 0 | $ (14,583,106) | $ 0 | $ 575 |
Unaudited Condensed Statement_3
Unaudited Condensed Statements Of Cash Flows - USD ($) | 1 Months Ended | 3 Months Ended |
Mar. 31, 2021 | Mar. 31, 2022 | |
Cash Flows from Operating Activities: | ||
Net income (loss) | $ (5,114) | $ 5,745,577 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Change in fair value of derivative liabilities | 0 | (6,034,000) |
Income from investments held in Trust Account | 0 | (21,280) |
Changes in operating assets and liabilities: | ||
Prepaid expenses - current | 0 | 66,191 |
Accounts payable | 4,496 | 63,752 |
Accrued expenses | 0 | (6,359) |
Franchise tax payable | 618 | 48,767 |
Net cash used in operating activities | 0 | (137,352) |
Cash Flows from Financing Activities: | ||
Proceeds from issuance of Class B common stock to Sponsor | 25,000 | 0 |
Net cash provided by financing activities | 25,000 | 0 |
Net change in cash | 25,000 | (137,352) |
Cash - beginning of the period | 0 | 387,206 |
Cash - end of the period | 25,000 | 249,854 |
Supplemental disclosure of noncash financing activities: | ||
Offering costs included in accounts payable | 320,976 | 0 |
Offering costs included in accrued expenses | $ 144,839 | $ 0 |
Description of Organization, Bu
Description of Organization, Business Operations and Going Concern | 3 Months Ended |
Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Organization, Business Operations and Going Concern | Note 1 — Description of Organization, Business Operations and Going Concern Mercato Partners Acquisition Corporation (the “Company”) is a blank check company incorporated in Delaware on February 22, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of March 31, 2022, the Company had not commenced any operations. All activity for the period from February 22, 2021 (inception) through March 31, 2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), described below, and since the Initial Public Offering, its search for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income to non-cash fluctuations The Company’s sponsor is Mercato Partners Acquisition Group, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on November 3, 2021. On November 8, 2021, the Company consummated its Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $12.1 million, of which $4.0 million was for underwriting commissions (see Note 5), $7.0 million was for deferred underwriting commissions (see Note 5) and approximately $1.1 million was for offering costs, of which approximately $343,000 was allocated to derivative warrant liabilities. The Company granted the underwriter a 45-day option Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 9,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant to the Sponsor, generating proceeds of $9.0 million (Note 4). Simultaneously with the sale of the Over-allotment Units, on November 23, 2021, the Company consummated a second closing of the Private Placement of an aggregate of 1,050,000 additional Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, with Sponsor pursuant to a Private Placement Warrants Purchase Agreement dated as of November 3, 2021. The second closing of the Private Placement generated additional aggregate gross proceeds of approximately $1.1 million. Upon the closing of the Initial Public Offering, over-allotment and the Private Placement, $233.45 million ($10.15 per Unit) of net proceeds, including the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement, was placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering, over-allotment and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholders’ meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.15 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount (“ASC”) 480-10-S99, redemption ASC 470-20. The ASC 480-10-S99. If a one-time charge additional paid-in capital If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 4) prior to this Initial Public Offering (the “Initial Stockholders”) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the Initial Public Offering, without the prior consent of the Company. The Sponsor, executive officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their Class A common stock in conjunction with any such amendment. Any such payments would be made in the form of a loan. The Company will have 15 months from the closing of the Initial Public Offering, or February 8, 2023, to consummate an initial Business Combination. However, if the Company anticipates that it may not be able to consummate the initial Business Combination within 15 months, the Company will, by resolution of its board if requested by the Sponsor, extend the period of time to consummate a Business Combination by an additional three months (for a total of 18 months to complete a Business Combination), subject to the Sponsor depositing additional funds into the Trust Account as set out below. In connection with any such extension, Public Stockholders will not be offered the opportunity to vote on or redeem their shares. In order to extend the time available for the Company to consummate the initial Business Combination for an additional three months, the Sponsor or its affiliates or designees must deposit into the Trust Account $0.10 per Public Share, or $2.3 million in the aggregate on or prior to the date of the deadline. If the Company is unable to complete a Business Combination within 15 months from the closing of the Initial Public Offering or a potential three-month extension period (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days a per-share price, In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Stockholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive its rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.15 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.15 per Public Share and (ii) the actual amount per Public Share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.15 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of March 31, 2022, the Company had approximately $250,000 in cash and working capital of approximately $342,000. In connection with management’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40 “Presentation Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 pandemic |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Summary of Significant Accounting Policies | Note 2 — Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K 10-K Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth Cash and Cash Equivalents The Company considers all highly liquid short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company d id Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income on investments held in the Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation (FDIC) coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The is re-assessed at ASC 825-10 “Financial The 21,550,000 warrants issued in connection with the Initial Public Offering and the Private Placement (including the 11,500,000 Public Warrants, as defined in Note 4, included in the Units and the 10,050,000 Private Placement Warrants) were recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at as non-current liabilities Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering and over-allotment that were directly related to the Initial Public Offering and over-allotment. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering and over-allotment based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current Class A Common Stock Subject to Possible Redemption As discussed in Note 1, all of the 23,000,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature. In accordance with the Accounting Standards Codification 480-10-S99-3A, “Classification and Measurement of a one-time charge additional paid-in capital Accordingly, at March 31, 2022 and December 31, 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. Gross proceeds from Initial Public Offering $ 230,000,000 Less: Fair value of Public Warrants at issuance (6,966,700 ) Offering costs allocated to Class A common stock subject to possible redemption (13,306,293 ) Plus: Accretion on Class A common stock subject to possible redemption amount 23,722,993 Class A common stock subject to possible redemption $ 233,450,000 Net Income (Loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net loss per share of common stock is calculated by dividing the net income by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 21,550,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock: For the Three Months Ended March 31, For The Period From February 22, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per common stock: Numerator: Allocation of net income (loss) $ 4,596,462 $ 1,149,115 $ — $ (5,114 ) Denominator: Basic and diluted weighted average common stock outstanding 23,000,000 5,750,000 — 3,684,211 Basic and diluted net income (loss) per common stock $ 0.20 $ 0.20 $ — $ (0.00 ) Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 or 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying condensed financial statements. |
Initial Public Offering
Initial Public Offering | 3 Months Ended |
Mar. 31, 2022 | |
Initial Public Offering [Abstract] | |
Initial Public Offering | Note 3 — Initial Public Offering On November 8, 2021, the Company consummated its Initial Public Offering of 20,000,000 Units, at $10.00 per Unit, generating gross proceeds of $200.0 million, and incurring offering costs of approximately $12.1 million, of which $4.0 million was for underwriting commissions (see Note 5), $7.0 million was for deferred underwriting commissions and approximately $1.1 million was for offering costs, of which approximately $343,000 was allocated to derivative warrant liabilities. On November 19, 2021, the underwriter exercised the Over-allotment Option in full and, on November 23, 2021 purchased 3,000,000 Over-allotment Units, generating additional gross proceeds to the Company of $30.0 million. The Company incurred additional offering costs of approximately $1.7 million in connection with the over-allotment, of which $600,000 was paid for underwriting commissions, and approximately $1.1 million was for deferred underwriting commissions. Each Unit consists of one share of Class A common stock, and one |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 4 — Related Party Transactions Founder Shares On March 4, 2021, the Sponsor purchased an aggregate of 5,750,000 Founder Shares for an aggregate purchase price of $25,000, or approximately $0.004 per share (the “Founder Shares”). Of the 5,750,000 Founder Shares outstanding, up to an aggregate of 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriter’s over-allotment option was not exercised so that the Initial Stockholders will maintain ownership of 20% of the issued and outstanding shares of common stock upon the completion of the Initial Public Offering. On November 19, 2021, the underwriter exercised the Over-allotment Option in full and, on November 23, 2021 purchased 3,000,000 Over-allotment Units. As such, 750,000 Class B common stock were no longer subject to forfeiture. In March 2021, each of the independent director nominees were transferred 40,000 Founder Shares (including the deemed beneficial ownership of 40,000 Founder Shares held by Context Partners Master Fund, L.P., an affiliated entity of one of the Company’s independent directors, Michael Rosen) and the Company’s Chief Financial Officer was transferred 35,000 Founder Shares. The transfer of the Founder Shares is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of March 31, 2022, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares that ultimately vest multiplied times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. The Initial Stockholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A common stock equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 9,000,000 Private Placement Warrants, at a price of $ 1.00 1.00 Each Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable (except The purchasers of the Private Placement Warrants agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants (except to permitted transferees) until 30 days after the completion of the initial Business Combination. Related Party Loans Promissory Note On March 4, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan is non-interest bearing Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans. Extension Loans If the Company anticipates that it may not be able to consummate the initial Business Combination within 15 months from the closing of the Initial Public Offering, the Company may, but is not obligated to, extend the period of time to consummate a Business Combination by an additional three months (for a total of 18 months to complete an initial Business Combination), as described in Note 1. In connection with such extension, the Sponsor or its affiliates or designees may loan the Company the required funds to deposit into the Trust Account of $0.10 per share of Class A common stock, for an aggregate of $2.3 million. Any such payments would be made in the form of a loan (the “Extension Loans”). The loans will be non-interest bearing Administrative Support Agreement On April 11, 2022, the Company entered into an agreement that provided that, commencing on the date of the agreement through the earlier of consummation of the initial Business Combination or the liquidation, the Company agreed to pay the Sponsor up to $15,000 per month for office space, administrative support and other services provided to members of the Company’s management team. For the three months ended March 31, 2022, the Company did no |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 5 — Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans or Extension Loans, if any (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares), are entitled to registration rights pursuant to a registration rights agreement signed upon the consummation of the Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will Underwriting Agreement The underwriter received an underwriting discount of $0.20 per Unit, or $4.6 million in the aggregate, paid upon the closing of the Initial Public Offering and over-allotment. An additional fee of $0.35 per Unit, or $8.05 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. These deferred underwriting commissions are included in the accompanying condensed balance sheets. |
Stockholders' Deficit
Stockholders' Deficit | 3 Months Ended |
Mar. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Deficit | Note 6 — Stockholders’ Deficit Preferred Stock Class A Common Stock Class B Common Stock The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis, an as-converted basis, Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, except as required by law. Each share of common stock will have one vote, subject to adjustment in the event the size of the Initial Public Offering increases or decreases on all such matters. However, only the holders of the Founder Shares will have the right to elect all of our directors prior to an initial Business Combination. In addition, prior to the completion of an initial Business Combination, holders of a majority of Founder Shares may remove a member of the board of directors for any reason. These provisions of the Company’s amended and restated certificate of incorporation may only be amended by a resolution passed by the holders of a majority of the Class B common stockholders. |
Derivative Warrant Liabilities
Derivative Warrant Liabilities | 3 Months Ended |
Mar. 31, 2022 | |
Derivative Warrant Liabilities [Abstract] | |
Derivative Warrant Liabilities | Note 7 — Derivative Warrant Liabilities As of March 31, 2022 and December 31, 2021, the Company had 11,500,000 Public Warrants and 10,050,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the shares of our Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial business combination, holders of warrants will have the right, until such time as there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants, and during any period when we will have failed to maintain an effective registration statement, to exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A common stock equals or exceeds $18.00” and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under the caption “Redemption of warrants when the price per Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so Redemption of warrants when the price per Class A common stock equals or exceeds $18.00 • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption which we refer to as the “30-day redemption • if, and only if, the last reported sale price (the “closing price”) of Class A common stock equals or exceeds $ 18.00 a 30-trading day The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A common stock is available throughout the 30-day redemption Redemption of warrants when the price per Class A common stock equals or exceeds $10.00 • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class A common shares to be determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A common stock; and • if, and only if, the closing price of our Class A common stock equals or exceeds $ 10.00 The “fair market value” of Class A common stock for the above purpose shall mean the volume weighted average price of our Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A common stock per warrant (subject to adjustment). If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 8 — Fair Value Measurements The following table presents information about the Company’s financial liabilities that are measured at fair value on a recurring basis as of the initial issuance date, March 31, 2022 and December 31, 2021, by level within the fair value hierarchy: March 31, 2022 Description Quoted Prices in Significant Other Significant Other Assets: Investments held in Trust Account – Money Market Fund $ 233,471,280 $ — $ — Liabilities: Derivative liabilities—Public Warrants $ 3,680,000 $ — $ — Derivative warrant liabilities—Private Placement Warrants $ — $ 3,216,000 $ — December 31, 2021 Description Quoted Prices in Significant Other Significant Other Liabilities: Derivative liabilities—Public Warrants $ 6,900,000 $ — $ — Derivative warrant liabilities—Private Placement Warrants $ — $ 6,030,000 $ — Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of Public Warrants was transferred from a Level 3 measurement to a Level 1 measurement when the Public Warrants were separately listed and traded in an active market in December 2021. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement in December 2021, as the transfer of Private Placement Warrants to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. There were no other transfers to/from Levels 1, 2, and 3 during the period from February 22, 2021 (inception) through March 31, 2022. Level 1 assets include investments in money market funds that invest solely in U.S. Government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 9 — Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date condensed financial statements were issued. Based upon this review, except as noted in Note 4, the Company determined that there have been no events that have occurred that would require adjustments to the disclosures in the condensed financial statements. |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation S-X. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K 10-K |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company d id |
Investments Held in Trust Account | Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in income on investments held in the Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Accordingly, the actual results could differ significantly from those estimates. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation (FDIC) coverage limit of $250,000. As of March 31, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Derivative Financial Instruments | Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The is re-assessed at ASC 825-10 “Financial The 21,550,000 warrants issued in connection with the Initial Public Offering and the Private Placement (including the 11,500,000 Public Warrants, as defined in Note 4, included in the Units and the 10,050,000 Private Placement Warrants) were recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at as non-current liabilities |
Offering Costs Associated with the Initial Public Offering | Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering and over-allotment that were directly related to the Initial Public Offering and over-allotment. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering and over-allotment based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption As discussed in Note 1, all of the 23,000,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature. In accordance with the Accounting Standards Codification 480-10-S99-3A, “Classification and Measurement of a one-time charge additional paid-in capital Accordingly, at March 31, 2022 and December 31, 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. Gross proceeds from Initial Public Offering $ 230,000,000 Less: Fair value of Public Warrants at issuance (6,966,700 ) Offering costs allocated to Class A common stock subject to possible redemption (13,306,293 ) Plus: Accretion on Class A common stock subject to possible redemption amount 23,722,993 Class A common stock subject to possible redemption $ 233,450,000 |
Net Income (Loss) Per Share of Common Stock | Net Income (Loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Net loss per share of common stock is calculated by dividing the net income by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the Initial Public Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 21,550,000 shares of Class A common stock in the calculation of diluted income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock: For the Three Months Ended March 31, For The Period From February 22, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per common stock: Numerator: Allocation of net income (loss) $ 4,596,462 $ 1,149,115 $ — $ (5,114 ) Denominator: Basic and diluted weighted average common stock outstanding 23,000,000 5,750,000 — 3,684,211 Basic and diluted net income (loss) per common stock $ 0.20 $ 0.20 $ — $ (0.00 ) |
Income Taxes | Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2022 or 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying condensed financial statements. |
Basis of Presentation and Summ
Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Class A Common Stock Subject to Possible Redemption | Accordingly, at March 31, 2022 and December 31, 2021, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. Gross proceeds from Initial Public Offering $ 230,000,000 Less: Fair value of Public Warrants at issuance (6,966,700 ) Offering costs allocated to Class A common stock subject to possible redemption (13,306,293 ) Plus: Accretion on Class A common stock subject to possible redemption amount 23,722,993 Class A common stock subject to possible redemption $ 233,450,000 |
Summary of Reconciliation of Basic and Diluted Net Income (loss) Per Share | The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of common stock: For the Three Months Ended March 31, For The Period From February 22, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per common stock: Numerator: Allocation of net income (loss) $ 4,596,462 $ 1,149,115 $ — $ (5,114 ) Denominator: Basic and diluted weighted average common stock outstanding 23,000,000 5,750,000 — 3,684,211 Basic and diluted net income (loss) per common stock $ 0.20 $ 0.20 $ — $ (0.00 ) |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Financial Liabilities Measured at Fair Value on a Recurring Basis | The following table presents information about the Company’s financial liabilities that are measured at fair value on a recurring basis as of the initial issuance date, March 31, 2022 and December 31, 2021, by level within the fair value hierarchy: March 31, 2022 Description Quoted Prices in Significant Other Significant Other Assets: Investments held in Trust Account – Money Market Fund $ 233,471,280 $ — $ — Liabilities: Derivative liabilities—Public Warrants $ 3,680,000 $ — $ — Derivative warrant liabilities—Private Placement Warrants $ — $ 3,216,000 $ — December 31, 2021 Description Quoted Prices in Significant Other Significant Other Liabilities: Derivative liabilities—Public Warrants $ 6,900,000 $ — $ — Derivative warrant liabilities—Private Placement Warrants $ — $ 6,030,000 $ — |
Description of Organization, _2
Description of Organization, Business Operations and Going Concern - Additional Information (Detail) - USD ($) | Nov. 23, 2021 | Nov. 08, 2021 | Mar. 31, 2022 | Dec. 31, 2021 |
Entity incorporation, Date of incorporation | Feb. 22, 2021 | |||
Proceeds from issuance initial public offering | $ 230,000,000 | |||
Class of warrant or right, Warrants issued during period | 21,550,000 | |||
Payments to acquire restricted investments | $ 233,450,000 | |||
Per share value of restricted assets | $ 10.15 | |||
Term of restricted investments | 185 days | |||
Temporary equity, Redemption price per share | $ 10.15 | |||
Minimum net worth required for compliance | $ 5,000,001 | |||
Percentage of public shares that can be transferred without any restriction | 15.00% | |||
Percentage of public shares to be redeemed in case business combination is not consummated | 100.00% | |||
Period within which business combination shall be consummated from the consummation of initial public offer | 15 months | |||
Date within which business combination shall be consummated | Feb. 8, 2023 | |||
Number of months used as an extension | 3 months | |||
Extended period within which business combination shall be consummated from the consummation of initial public offer | 18 months | |||
Price per share to be deposited in order to extend the time available to consummate the initial Business Combination by three months | $ 0.10 | |||
Amount to be deposited in order to extend the time available to consummate the initial Business Combination by three months | $ 2,300,000 | |||
Number of days within which the public shares shall be redeemed | 10 days | |||
Liquidation basis of accounting, Accrued costs to dispose of assets and liabilities | $ 100,000 | |||
Percentage of redemption | 100.00% | |||
Net asset value per share | $ 10.15 | |||
Share price | $ 10.15 | |||
Cash | $ 249,854 | $ 387,206 | ||
Working capital | $ 342,000 | |||
Share Price less than Ten Point Fifteen USD [Member] | ||||
Share price | $ 10.15 | |||
Minimum [Member] | ||||
Prospective assets of Acquiree as a percentage of fair value of assets in the trust account | 80.00% | |||
Equity method investment, Ownership percentage | 50.00% | |||
IPO [Member] | ||||
Stock issued during period, Shares | 20,000,000 | |||
Shares issued, Price per share | $ 10 | |||
Total offering cost | $ 12,100,000 | |||
Payments for underwriting expense | 4,000,000 | |||
Deferred underwriting commissions | 7,000,000 | |||
Payments of stock issuance costs | 1,100,000 | |||
Offering cost allocated to derivative warrant liabilities | $ 343,000 | |||
Over-Allotment Option [Member] | ||||
Stock issued during period, Shares | 3,000,000 | |||
Total offering cost | $ 1,700,000 | |||
Payments for underwriting expense | 600,000,000,000 | |||
Deferred underwriting commissions | $ 1,100,000 | |||
Sponsor [Member] | Private Placement Warrants [Member] | Private Placement [Member] | ||||
Class of warrant or right, Warrants issued during period | 1,050,000 | 9,000,000 | ||
Class of warrant or right, Warrants issued during period, Price per warrant | $ 1 | $ 1 | ||
Proceeds from issuance of warrants | $ 1,100,000 | $ 9,000,000 | ||
Common Class A [Member] | ||||
Temporary equity, Redemption price per share | $ 10.15 | $ 10.15 | ||
Share price | $ 11.50 | |||
Common Class A [Member] | IPO [Member] | ||||
Stock issued during period, Shares | 20,000,000 | |||
Shares issued, Price per share | $ 10 | |||
Proceeds from issuance initial public offering | $ 200,000,000 | |||
Common Class A [Member] | Over-Allotment Option [Member] | ||||
Stock issued during period, Shares | 3,000,000 | |||
Option vesting period | 45 days | |||
Stock issued during period, Value | $ 30,000,000 | |||
Common stock, Shares subscribed but unissued | 3,000,000 |
Basis of Presentation and Sum_3
Basis of Presentation and Summary of Significant Accounting Policies - Summary of Class A Common Stock Subject to Possible Redemption (Detail) - USD ($) | 3 Months Ended | |
Mar. 31, 2022 | Dec. 31, 2021 | |
Temporary Equity [Abstract] | ||
Gross proceeds from Initial Public Offering | $ 230,000,000 | |
Fair value of Public Warrants at issuance | (6,966,700) | |
Offering costs allocated to Class A common stock subject to possible redemption | (13,306,293) | |
Accretion on Class A common stock subject to possible redemption amount | 23,722,993 | |
Class A common stock subject to possible redemption | $ 233,450,000 | $ 233,450,000 |
Basis of Presentation and Sum_4
Basis of Presentation and Summary of Significant Accounting Policies - Summary of Reconciliation of Basic and Dilutes Net Income (loss) Per Share (Detail) - USD ($) | 1 Months Ended | 3 Months Ended |
Mar. 31, 2021 | Mar. 31, 2022 | |
Numerator: | ||
Allocation of net income (loss) | $ (5,114) | $ 5,745,577 |
Common Class A [Member] | ||
Numerator: | ||
Allocation of net income (loss) | $ 0 | $ 4,596,462 |
Denominator: | ||
Basic and diluted weighted average common stock outstanding | 0 | 23,000,000 |
Basic and diluted net income (loss) per common stock | $ 0 | $ 0.20 |
Common Class B [Member] | ||
Numerator: | ||
Allocation of net income (loss) | $ (5,114) | $ 1,149,115 |
Denominator: | ||
Basic and diluted weighted average common stock outstanding | 3,684,211 | 5,750,000 |
Basic and diluted net income (loss) per common stock | $ 0 | $ 0.20 |
Basis of Presentation and Sum_5
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) | 3 Months Ended | ||
Mar. 31, 2022 | Dec. 31, 2021 | Mar. 31, 2021 | |
Cash equivalents | $ 0 | $ 0 | |
Term of Restricted Investments | 185 days | ||
Cash, FDIC Insured amount | $ 250,000 | ||
Class of Warrant or Right Warrants Issued During Period | 21,550,000 | ||
Unrecognized tax benefits | $ 0 | $ 0 | |
Unrecognized tax benefits, Income tax penalties and interest accrued | $ 0 | $ 0 | |
Common Class A [Member] | |||
Temporary equity, Shares outstanding | 23,000,000 | 23,000,000 | |
Class of warrant or right, Number of securities called by warrants or rights | 21,550,000 | ||
Private Placement Warrants [Member] | |||
Class of warrants or rights outstanding | 10,050,000 | 10,050,000 | |
Public Warrants [Member] | |||
Class of warrants or rights outstanding | 11,500,000 |
Initial Public Offering - Addit
Initial Public Offering - Additional Information (Detail) - USD ($) | Nov. 23, 2021 | Nov. 08, 2021 | Mar. 31, 2022 | Dec. 31, 2021 |
Initial Public Offering [Line Items] | ||||
Gross proceeds from initial public offering | $ 200,000,000 | |||
Deferred underwriting commissions | $ 8,050,000 | $ 8,050,000 | ||
Common Class A [Member] | ||||
Initial Public Offering [Line Items] | ||||
Number of shares included in unit | 1 | |||
Public Warrants [Member] | ||||
Initial Public Offering [Line Items] | ||||
Number of warrants included in unit | 0.50 | |||
Public Warrants [Member] | Common Class A [Member] | ||||
Initial Public Offering [Line Items] | ||||
Class of warrants or rights exercise price per share | $ 11.50 | $ 11.50 | ||
Class of warrants or rights number of shares called by each warrant or right | 1 | |||
IPO [Member] | ||||
Initial Public Offering [Line Items] | ||||
Stock issued during period, Shares | 20,000,000 | |||
Shares issued, Price per share | $ 10 | |||
Payment of offering costs | $ 12,100,000 | |||
Payment of underwriting commission | 4,000,000 | |||
Deferred underwriting commissions | 7,000,000 | |||
Payment of other offering costs | $ 1,100,000 | |||
IPO [Member] | Common Class A [Member] | ||||
Initial Public Offering [Line Items] | ||||
Stock issued during period, Shares | 20,000,000 | |||
Shares issued, Price per share | $ 10 | |||
IPO [Member] | Allocated To Derivative Warrant Liabilities [Member] | ||||
Initial Public Offering [Line Items] | ||||
Payment of other offering costs | $ 343,000 | |||
Over-allotment option [Member] | ||||
Initial Public Offering [Line Items] | ||||
Stock issued during period, Shares | 3,000,000 | |||
Payment of offering costs | 1,700,000 | |||
Payment of underwriting commission | 600,000 | |||
Deferred underwriting commissions | 1,100,000 | |||
Gross proceeds additional on issue of shares | $ 30,000,000 | |||
Over-allotment option [Member] | Common Class A [Member] | ||||
Initial Public Offering [Line Items] | ||||
Stock issued during period, Shares | 3,000,000 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Detail) - USD ($) | Mar. 31, 2022 | Nov. 23, 2021 | Nov. 08, 2021 | Mar. 04, 2021 | Mar. 31, 2021 | Apr. 11, 2022 | Dec. 31, 2021 | Nov. 03, 2021 |
Related Party Transaction [Line Items] | ||||||||
Stock issued during the period for services value | $ 25,000 | |||||||
Share price | $ 10.15 | |||||||
Private Placement Warrants [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Class of warrants or rights exercise price per share | $ 1 | |||||||
Redemption trigger price | $ 10 | |||||||
Private Placement Warrants [Member] | Private Placement Warrant Purchase Agreement [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Class of warrants or rights issued during the period units | 1,050,000 | 9,000,000 | ||||||
Gross proceeds from private placement | $ 1,100,000 | $ 9,000,000 | ||||||
Founder [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued during the period for services value | $ 25,000 | |||||||
Over-Allotment Option [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued during the period shares new issues | 3,000,000 | |||||||
Sponsor [Member] | Sponsor Promissory Note [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Debt instrument face value | $ 300,000 | |||||||
Due to related parties current | $ 0 | $ 162,000 | $ 0 | |||||
Sponsor [Member] | Sponsor Working Capital Loan [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Debt instrument convertible into equity related warrants | $ 1,500,000 | |||||||
Debt instrument conversion price per share | $ 1.50 | |||||||
Bank Overdrafts | $ 0 | 0 | ||||||
Sponsor [Member] | Extension Loan Sponsor [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Debt instrument face value | 2,300,000 | |||||||
Due to related parties current | $ 0 | $ 0 | ||||||
Debt instrument conversion price per share | $ 1 | |||||||
Threshold period for consummation of business combination one | 15 months | |||||||
Threshold Period For Consummation Of Business Combination Two | 18 months | |||||||
Debt instrument face value per share | $ 0.10 | |||||||
Sponsor [Member] | Administrative Support Agreement [Member] | Subsequent event [member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Related party transaction expenses payable per month rent of office space and administrative support | $ 15,000 | |||||||
Sponsor [Member] | Private Placement Warrants [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Class of warrants or rights exercise price per share | $ 1 | $ 1 | ||||||
Common Class B [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Stock issued during the period for services shares | 5,750,000 | |||||||
Common stock shares outstanding | 5,750,000 | 5,750,000 | ||||||
Common Class B [Member] | Founder [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Interse transfer of shares | 40,000 | |||||||
Lock in period | 1 year | |||||||
Share price | $ 12 | |||||||
Number of trading days for determining the share price for removing the restriction on share transfer | 20 days | |||||||
Number of consecutive trading days for determining the share price for removing the restriction on share transfer | 30 days | |||||||
Lock in period two | 150 days | |||||||
Common Class B [Member] | Founder [Member] | Context Partners Master Fund LP [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Interse transfer of shares | 40,000 | |||||||
Common Class B [Member] | Founder [Member] | Chief Financial Officer [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Interse transfer of shares | 35,000 | |||||||
Class A Common Stock [Member] | ||||||||
Related Party Transaction [Line Items] | ||||||||
Common stock shares outstanding | 0 | 0 | ||||||
Share price | $ 11.50 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) $ / shares in Units, $ in Thousands | 3 Months Ended |
Mar. 31, 2022USD ($)$ / shares | |
Loss Contingencies [Line Items] | |
Underwriting discount amount paid per share | $ / shares | $ 0.20 |
Payment of underwriting discount | $ | $ 4,600 |
Deferred underwriting commission value per share | $ / shares | $ 0.35 |
Deferred underwriting commission non current | $ | $ 8,050 |
Stockholders' Deficit - Additio
Stockholders' Deficit - Additional Information (Detail) - $ / shares | Mar. 31, 2022 | Dec. 31, 2021 |
Common stock shares outstanding after being converted from previous class to the current class as a percentage of total | ||
Preferred stock, Shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, Par or stated value per share | $ 0.0001 | $ 0.0001 |
Preferred stock, Shares issued | 0 | 0 |
Preferred stock, Shares outstanding | 0 | 0 |
Common stock shares outstanding after being converted from previous class to the current class as a percentage of total | 20.00% | 20.00% |
Common Class A [Member] | ||
Common stock shares outstanding after being converted from previous class to the current class as a percentage of total | ||
Common stock, Shares authorized | 100,000,000 | 100,000,000 |
Common stock, Par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock, Shares issued | 0 | 0 |
Common stock, Shares outstanding | 0 | 0 |
Temporary equity Shares issued | 23,000,000 | 23,000,000 |
Temporary equity, Shares outstanding | 23,000,000 | 23,000,000 |
Common Class B [Member] | ||
Common stock shares outstanding after being converted from previous class to the current class as a percentage of total | ||
Common stock, Shares authorized | 10,000,000 | 10,000,000 |
Common stock, Par or stated value per share | $ 0.0001 | $ 0.0001 |
Common stock, Shares issued | 5,750,000 | 5,750,000 |
Common stock, Shares outstanding | 5,750,000 | 5,750,000 |
Derivative Warrant Liabilities
Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares | Mar. 31, 2022 | Dec. 31, 2021 | Nov. 23, 2021 | Nov. 08, 2021 |
Derivative Warrant Liabilities [Line Items] | ||||
Share price | $ 10.15 | |||
Class A Common Stock [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Share price | $ 11.50 | |||
Public Warrants [Member} | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Class of warrants or rights outstanding | 11,500,000 | |||
Public Warrants [Member} | Class A Common Stock [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Number of days after the business combination when the warrants are eligible to be exercised | 30 days | |||
Number of days after the business combination within which the securities shall be registered | 20 days | |||
Number of days after the business combination within which the registration of securities shall be made effective | 60 days | |||
Class of warrants or rights exercise price per share | $ 11.50 | $ 11.50 | ||
Class of warrants or rights term | 5 years | |||
Number of trading days for determining the fair market value of common stock | 10 days | |||
Public Warrants [Member} | Class A Common Stock [Member] | Prospective Event Triggering the Redemption or Exercise Price of Warrants [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Shares issued price per share | $ 9.20 | |||
Proceeds from equity and other related securities to be used for the consummation of business combination as a percentage of total | 60.00% | |||
Number of trading days for determining the volume weighted average price per shares | 20 days | |||
Volume weighted average price of shares | $ 9.20 | |||
Public Warrants [Member} | Class A Common Stock [Member] | Prospective Event Triggering the Redemption or Exercise Price of Warrants [Member] | Warrant Trigger Price One [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Redemption trigger price | $ 18 | |||
Exercise price of warrants as a percentage of newly issued price | 115.00% | |||
Exercise price of warrants as a percentage of market price | 115.00% | |||
Share price | $ 18 | |||
Public Warrants [Member} | Class A Common Stock [Member] | Prospective Event Triggering the Redemption or Exercise Price of Warrants [Member] | Warrant Trigger Price Two [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Redemption trigger price | 10 | |||
Share price | $ 10 | |||
Warrant redemption price as a percentage of market value | 180.00% | |||
Warrant redemption price as a percentage of newly issued price | 180.00% | |||
Public Warrants [Member} | Class A Common Stock [Member] | Prospective Event Triggering the Redemption of Warrants [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Share price | $ 18 | |||
Public Warrants [Member} | Class A Common Stock [Member] | Prospective Event Triggering the Redemption of Warrants [Member] | Warrant Redemption Trigger Price One [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Class of warrant or rights redemption price per units | $ 0.01 | |||
Minimum notice period to be given to warrant holders prior to redemption | 30 days | |||
Number of trading days for determining the share price | 20 days | |||
Number of consecutive trading days for determining the share price | 30 days | |||
Period during the registration statement shall remain effective as a condition to redeem warrants | 30 days | |||
Public Warrants [Member} | Class A Common Stock [Member] | Prospective Event Triggering the Redemption of Warrants [Member] | Warrant Redemption Trigger Price Two [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Share price | $ 10 | |||
Class of warrant or rights redemption price per units | $ 0.10 | |||
Minimum notice period to be given to warrant holders prior to redemption | 30 days | |||
Private Placement Warrants [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Class of warrants or rights outstanding | 10,050,000 | 10,050,000 | ||
Redemption trigger price | $ 10 | |||
Private Placement Warrants [Member] | Class A Common Stock [Member] | ||||
Derivative Warrant Liabilities [Line Items] | ||||
Lock in period of warrants | 30 days |
Fair Value Measurements - Summa
Fair Value Measurements - Summary of Financial Liabilities Measured At Fair Value on a Recurring Basis (Detail) - Fair Value Recurring [Member] - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
Fair Value Level 1 [Member} | Investments held in Trust Account – Money Market Fund [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Investments held in Trust Account | $ 233,471,280 | |
Fair Value Level 1 [Member} | Warrant [Member] | Public Warrants [Member} | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative warrant liabilities | 3,680,000 | $ 6,900,000 |
Fair Value Level 2 [Member} | Warrant [Member] | Private Placement Warrants [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative warrant liabilities | $ 3,216,000 | $ 6,030,000 |